1Becattini C, Agnelli G, Prandoni P, et al. A prospective study on cardiovascular events after acute pulmonary embolism.Eur Heart J,2005,26:77-83.
2Sbrensen HT, Horvath-Puho E, Pedersen L, et al. Venous throm- boembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.Lancet,2007,370: 1773-1779.
3Prandoni P, Ghirarduzzi A, Prins MH, et al. Venous thromboem- bolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost,2006,4:1891-1896.
4Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med,2003,348: 1435-1441.
5McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study, Diabetes Care,2005,28:385-390.
6Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and deatb, J Am Coll Car- diol,2007,49:403-414.
7Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men, Stroke,2006,37:806-811.
8Curb JD, Abbott RD, Rodriguez BL, et al. High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program. Am J Epidemiol,2004,160:150-157.
9Jang MJ, Choi WI, Bang SM, et al. Metabolic syndrome is associ- ated with venous thromboembolism in the Korean population.Arte- rioscler Thromb Vase Biol,2009,29:311-315.
10Walter A, Cecilia B, Timothy B, et al. Cardiovascular risk factors and venous hromboembolism A meta -analysis. Circula- tion,2008,117:93-102.
2Lowe G. Coagulation, fibrinolysis and cardiovascular disease [J]. Fibrinolysis,1999,13(3) :91-92.
3Lip GY, Blann A. von Willebrand factor : a marker of endothelial dysfunction in vascular disorders [ J ]. Cardiovasc Res,1997,34(2) :255 -265.
4Binder B R, Christ G, Gruber F, et al. Plasminogen activator inhibitor physiological and pathophysiological roles [ J ]. News Physiol Sci,2002,17(2) : 56-61.
5Buchwalter G, Gross C , Wasylyk B, et al. The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression [J]. Mol Cell Biol,2005,25 (24) : 10853-10862.
6Blann A D, McCollum C N. yon willebrand factor, endothelial danmage and atherosclerotis [ J ]. Eur J Vasc Surg, 1994,8 (1):10-15.
7Moncada S, Vane J R. Prostacyclin and its clinical applications [J]. Ann Clin Res,1984,16 (1) :241-252.
8Arcaro G, Zenere B M , Travia D, et al. Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects [ J ]. Atherosclerosis, 1995, 114 ( 2 ) : 247- 254.
9Curb JD, Abbott RD, Rodriguez BL, et al. High density lipopr9tein cholesterol and the risk of stroke in elderly men: the Honolulu heart program[J]. Am J Epidemiol, 2004, 160: 150-157.
10Miller M, Seidler A, witerovich PO, et al. Long-term predictors of subsequent cardiovascular events with coronary artery disease and desirable levels of plasma total choleaterol [J]. Circulation, 1992, 86: 1165-1170.
